Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline - Wikidata - wikimedia - TriplyDB

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

http://www.wikidata.org/entity/Q29301826

about

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan Interventions for hirsutism (excluding laser and photoepilation therapy alone)Interventions for hirsutism excluding laser and photoepilation therapy Sex and gender issues in competitive sports: investigation of a historical case leads to a new viewpoint Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria Endocrine-disrupting chemicals: an Endocrine Society scientific statement Genetic, hormonal and metabolic aspects of PCOS: an update Polycystic Ovary Syndrome May Be an Autoimmune Disorder Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists Poly Cystic Ovarian Syndrome: An Updated Overview Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress Value of ultrasonography in the diagnosis of polycystic ovary syndrome - literature review Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome Features of Polycystic Ovary Syndrome in adolescence Complications and challenges associated with polycystic ovary syndrome: current perspectives Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue Neuroendocrine dysfunction in polycystic ovary syndrome.The genetic basis of female reproductive disorders: etiology and clinical testing Hypertension: what's sex got to do with it?The Bologna criteria for poor ovarian response: a contemporary critical appraisal Animal models of the polycystic ovary syndrome phenotype The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS Functional genomics of PCOS: from GWAS to molecular mechanisms Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase/17, 20-lyase activity in vivo CLINICAL PRACTICE. Polycystic Ovary Syndrome.Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry Should all women with PCOS be treated for insulin resistance?Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants.Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls--implications for regulation of pubertal maturation.

P2860

Q21245262-39B63FA0-60F6-4D83-8894-293A83DA118B Q24186393-72DADBE4-6D14-436C-AD1A-25376C755C27 Q24201916-C084F774-04B2-4E97-A7C6-2A3AA289F1C6 Q24604042-4EF388FA-5269-4005-A2C5-22814CC2D72C Q24626844-5E1F4D56-45B4-4834-92BC-D8C1788A80F1 Q24632310-91CB981C-BA12-409E-9F52-BAEF17BFC8E4 Q24651457-D7D498A4-42E8-4B82-ADAA-43ED4B2EE113 Q26740034-C2676836-B2E7-4CC3-9A61-C232C47ABC5A Q26747598-8DC72F3D-6C70-426C-957B-B98AA479BA3F Q26749044-C87DC7E8-F5D8-410D-8363-08A775BB48BE Q26752564-C9010DF6-DEFA-42D3-A515-3E03807713D9 Q26773554-AD91B689-497B-41B3-9D3F-87843F177483 Q26774941-C86C11F1-E89D-4336-BBB3-B6AD58DA747C Q26781169-F7E63B86-C891-4744-A263-58CB5A1BDB7A Q26782435-4995E0C4-F2C3-4390-B458-92F0C4C25B27 Q26799566-25F22A65-77D7-4B04-9EE7-D47F67552EC2 Q26828765-E78BDCB2-E772-4FF1-9B3F-BEC907B7A577 Q26830631-FDE712F9-282B-40BE-9B99-509CF105C5B5 Q26852742-C12E2F96-FDA8-4E0D-9D4B-2AFEA93B8019 Q26865875-36B1E989-7B61-4F50-843D-6364DAF2A533 Q26866656-9DB0D915-97D1-4053-B504-43E73633F4DD Q27021821-66A84913-6B0B-4A5D-A52D-A9FACDFF3D3C Q27024884-A680FDAD-5632-46A2-8429-E0CB5E854F2F Q27694511-67029C6E-2C0E-4070-8D7B-876D4FCA0213 Q28077960-83008455-1CDF-4133-858F-04F9FD1D40E0 Q28083015-42F9125F-2AB5-4652-843C-D343646CAD5D Q28390200-7F5C0A65-7D1E-4B36-91BA-2F09DBD84F3A Q28394688-25AA6C71-3B9E-464C-BE09-C4E7E98B13C3 Q28475309-52F68E45-4B1E-4D74-90C9-BFE2E53DEF0A Q28550174-7785C07F-CBB2-4BAC-9061-96A5015BD165 Q28582335-4FA3516B-26D8-44F7-9108-EC8398D2C9CD Q29248890-F4F65E92-16C9-44E4-BC02-851FD1385017 Q30356822-32098617-584D-4543-9D4D-EFE045E19D5C Q30370866-56618D80-E3C2-4944-9F67-BCC03EC7707D Q30384617-A901A76C-89C3-4111-A71A-0B06A51CD0C7 Q30415504-C56EBA5D-0421-4B62-AF82-CF57D76850B8 Q30423117-C72EA9BB-0709-4F64-A14A-ABC7D8BAC68F Q30429467-163ED396-C65A-4192-B39D-1A9932B7212E Q30432558-2E17E9AE-35E4-442A-ABE7-0E4236F748A6 Q30435666-13540E80-1A65-4246-A520-D92966F46DC8

P2860

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

http://www.wikidata.org/entity/Q29301826

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Criteria for Defining Polycyst ...... rogen Excess Society Guideline

@ast

Criteria for Defining Polycyst ...... rogen Excess Society Guideline

@en

type

label

Criteria for Defining Polycyst ...... rogen Excess Society Guideline

@ast

Criteria for Defining Polycyst ...... rogen Excess Society Guideline

@en

prefLabel

Criteria for Defining Polycyst ...... rogen Excess Society Guideline

@ast

Criteria for Defining Polycyst ...... rogen Excess Society Guideline

@en

P1433

Q29301826-81C97B13-FF6F-4986-BBD1-FB33610C57B4

P1476

Q29301826-16FAF91E-E5BA-4B7F-8DA1-97174E2D6967

P2093

Q29301826-150CD186-D4AA-4DBA-A801-FDF185FD96F9

Q29301826-2F4B2360-91FB-4B7A-ADBA-D7358EF542DD

Q29301826-45CB120F-0E4C-4A21-9775-1C887EDF1F94

Q29301826-68B3673E-6624-4A15-A61D-D77B9068FEE9

Q29301826-B6D0CB44-F06B-4C64-8A02-EBAB1615DDA5

Q29301826-D0ABC245-2BDD-4764-AB5C-AEF2B154A727

Q29301826-D1533ED8-5F5E-4D2D-94C9-375A6ED20BEC

Q29301826-DB8D05FA-807B-4C3C-9140-53D4346B42C5

P304

Q29301826-22974A32-CA66-4176-B72A-E8FF1331E59D

P31

Q29301826-843830B8-D30A-450E-8B3E-9869B7CBD6E3

P3181

Q29301826-79639626-7418-43CE-9DBA-9E628374764B

P356

Q29301826-6A698517-2BFC-44B8-9221-5140FB2E2E9A

P407

Q29301826-94B2D65E-4903-422E-A3CC-7CE74A777F97

P433

Q29301826-4D592F3D-FC62-47AB-A3CD-A24989EFFF56

P478

Q29301826-E9B5FDF5-6A6F-48FA-9410-BF4E38250AB7

P50

Q29301826-28239804-BA92-4530-B045-CDE3B7D78428

Q29301826-56B7E4B7-E24B-4E64-AECB-C474769C0872

Q29301826-716B5C68-3EE4-4349-A533-D779E7EE8146

Q29301826-979BAA31-CDF8-4099-9015-7CC73CF04F12

P577

Q29301826-51E88FD8-0E34-4423-9FBB-2E2F9047F1B5

P5875

Q29301826-847B6267-C2AF-4C64-9A0F-35C168BE927C

P698

Q29301826-79020B58-D620-419F-A22C-17B91BCE90C2

P921

Q29301826-0EE0EBCF-4017-49BC-998F-A6AFFCFB9962

P3181

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Positions statement: criteria ...... rogen Excess Society guideline

@en

P2093

Androgen Excess Society

http://www.w3.org/2001/XMLSchema#string

Ann E Taylor

http://www.w3.org/2001/XMLSchema#string

Enrico Carmina

http://www.w3.org/2001/XMLSchema#string

Evanthia Diamanti-Kandarakis

http://www.w3.org/2001/XMLSchema#string

Onno E Janssen

http://www.w3.org/2001/XMLSchema#string

Ricardo Azziz

http://www.w3.org/2001/XMLSchema#string

Selma F Witchel

http://www.w3.org/2001/XMLSchema#string

Walter Futterweit

http://www.w3.org/2001/XMLSchema#string

P304

4237-4245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

70473

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/JC.2006-0178

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Richard S. Legro

Héctor F Escobar-Morreale

Robert J Norman

Didier Dewailly

P577

2006-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6849198

http://www.w3.org/2001/XMLSchema#string

P698

16940456

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome